- Home
- SRL vs PMVP Comparison
SRL vs PMVP Comparison
Compare SRL & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRL | PMVP |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.0M | 68.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | SRL | PMVP |
|---|---|---|
| Price | $7.09 | $1.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 3.4K | ★ 249.1K |
| Earning Date | 12-30-2025 | 11-12-2025 |
| Dividend Yield | ★ 15.46% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $24,535,042.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.13 | $0.81 |
| 52 Week High | $9.99 | $1.84 |
Technical Indicators
Market Signals| Indicator | SRL | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 68.54 | 44.68 |
| Support Level | $5.50 | $1.30 |
| Resistance Level | $6.00 | $1.44 |
| Average True Range (ATR) | 0.22 | 0.08 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 68.06 | 23.53 |
Price Performance
Historical ComparisonAbout SRL Scully Royalty Ltd.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.